rethinkTHC Search
Menu
Study breakdown

Intravenous THC caused paranoia in vulnerable individuals by increasing negative emotions and unusual experiences

Randomized Controlled TrialStrong evidence
The takeaway

In 121 people prone to paranoia, intravenous THC significantly increased paranoid thoughts, with the mechanism being increased anxiety, worry, depression, and anomalous perceptual experiences.

Read this if you've experienced paranoia from cannabis and want to understand why.

Negative affect and anomalous experiences fully explained THC-induced paranoia

What the researchers found

This was the largest study of intravenous THC, randomizing 121 individuals with existing paranoid ideation to receive THC, placebo, or THC with prior cognitive awareness training. Paranoia was measured through a real social situation, virtual reality simulation, self-report, and interviewer assessment.

THC significantly increased paranoia, and the mediating mechanism was identified: THC increased negative affect (anxiety, worry, depression, negative self-thoughts) and anomalous experiences (unusual perceptions, altered sense of meaning). These two factors fully accounted for the increase in paranoia. Changes in working memory did not contribute to paranoia.

Making participants aware of THC's effects beforehand did not significantly reduce paranoid responses, suggesting that cognitive preparation alone is insufficient to prevent cannabis-induced paranoia in vulnerable individuals.

Why it matters

This study definitively demonstrated that THC causes paranoia in vulnerable individuals and identified the mechanism: it works through negative emotions and unusual perceptual experiences, not through cognitive impairment. This understanding could inform both prevention strategies and therapeutic approaches.

The numbers in context

121 participants randomized to 3 groups. THC significantly increased paranoia, negative affect, and anomalous experiences. Negative affect and anomalous experiences fully mediated the THC-paranoia relationship. Working memory changes did not contribute. Cognitive awareness training had little impact.

How the study worked

Randomized, placebo-controlled, between-groups study. 121 individuals with pre-existing paranoid ideation received placebo, intravenous THC, or THC with cognitive awareness training. Paranoia assessed via real social situation, immersive virtual reality, self-report, and interviewer measures. Mediation analysis tested causal pathways.

What this study cannot tell us

Intravenous THC administration does not replicate typical cannabis use. Only individuals with pre-existing paranoid ideation were studied, so results may not apply to those without this vulnerability. Single-dose design. The between-groups design (rather than within-subject) may introduce individual variability.

How to read the evidence

Largest intravenous THC study with rigorous methodology: randomized, placebo-controlled, multi-method paranoia assessment, and mediation analysis.

When this study was published

Published in 2015. Considered a landmark study in understanding cannabis-induced paranoia.

The bigger picture

Paranoia is both a common cannabis side effect and a core feature of psychotic disorders. Understanding that THC triggers paranoia through emotional and perceptual disruption (rather than cognitive impairment) connects cannabis research to broader understanding of psychosis mechanisms.

Questions still open

  • Could anxiolytic pre-treatment prevent cannabis-induced paranoia? Does CBD counteract the emotional and perceptual mechanisms that drive paranoia? Are there individuals with paranoid ideation who do not become more paranoid after THC?

Common questions

Why does cannabis make some people paranoid?
This study showed THC causes paranoia by increasing negative emotions (anxiety, worry, depression) and unusual perceptual experiences. These combined effects drive paranoid thinking. Cognitive impairment was not part of the mechanism.
Can you prevent cannabis paranoia by knowing what to expect?
In this study, participants who received cognitive awareness training about THC's effects were not significantly protected from paranoia, suggesting that knowing what to expect is not sufficient to prevent it in vulnerable individuals.

Read the original research

How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia.

Schizophrenia bulletin, 41(2), 391-9

Citation

Freeman, Daniel; Dunn, Graham; Murray, Robin M; Evans, Nicole; Lister, Rachel; Antley, Angus; Slater, Mel; Godlewska, Beata; Cornish, Robert; Williams, Jonathan; Di Simplicio, Martina; Igoumenou, Artemis; Brenneisen, Rudolf; Tunbridge, Elizabeth M; Harrison, Paul J; Harmer, Catherine J; Cowen, Philip; Morrison, Paul D. (2015). How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia.. Schizophrenia bulletin, 41(2), 391-9. https://doi.org/10.1093/schbul/sbu098

Explore the wider topic